Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Bliss GVS Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:506197NSE Symbol: BLISSGVSP/E(TTM):24.64
ISIN Demat:INE416D01022Div & Yield %:0.31EPS(TTM):6.55
Book Value(Rs):100.3969303Market Cap ( Cr.):1701.89Face Value(Rs):1
    Change Company 
Date Headline
11-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Copy of Newspaper Publication
10-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Copy of Newspaper Publication
10-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Meeting
09-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Record Date
08-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Updates
08-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Copy of Newspaper Publication
04-Jul-25 Bliss GVS Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
02-Jul-25 Bliss GVS Pharma Ltd - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And..
01-Jul-25 Bliss GVS Pharma Ltd - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
01-Jul-25 Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - ESOP/ESOS/ESPS
<< < 1 2 3 4   > >>